Literature DB >> 30931227

Translabyrinthine Excision of Vestibular Schwannoma with Concurrent Cochlear Implantation: Systematic Review.

Nicholas J Thompson1, Brendan P O'Connell1, Kevin D Brown1.   

Abstract

Objectives  Hearing rehabilitation is an important management aspect of patients undergoing excision of vestibular schwannomas. Studies have shown cochlear implantation (CI) is possible at the time of tumor excision via a translabyrinthine approach. Primary objectives of this report are (1) to review prospective studies pertaining to outcomes of concurrent CI and translabyrinthine tumor removal in detail and (2) perform an aggregate analysis of outcomes for case reports and series. Design  Systematic review based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Setting  Review of literature using PubMed and Cochrane databases. Participants  Eligibility included patients undergoing translabyrinthine excision of vestibular schwannoma with concurrent CI. Main Outcome Measures  Open-set speech discrimination scores, sound localization, patient-reported outcome measures. Results  Forty-one subjects were identified. Two prospective studies have been performed, which showed improvement in speech localization and patient-reported outcome measures. While the majority of patients achieved open set speech recognition, data pertaining to improvement in speech perception were variable. Approximately 85% of subjects had audibility with their CI. Of those that achieved open-set speech discrimination, 75% could be classified as either intermediate or high performers. The majority of low performers in open-set speech either endorsed subjective benefit or demonstrated improvement compared to preoperative measures. There was a high risk of selection and reporting bias. Conclusions  The majority of patients undergoing translabyrinthine excision of vestibular schwannoma with concurrent CI achieve open set speech perception, with 75% of these patients meeting criteria for being intermediate to high performers. Additional benefits include improved subjective hearing measures, decreased tinnitus, and improved sound localization.

Entities:  

Keywords:  cochlear implantation; hearing outcomes; hearing rehabilitation; review; schwannoma; translabyrinthine

Year:  2019        PMID: 30931227      PMCID: PMC6438800          DOI: 10.1055/s-0038-1677491

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  30 in total

1.  The prognostic value of promontory electric auditory brain stem response in pediatric cochlear implantation.

Authors:  T P Nikolopoulos; S M Mason; K P Gibbin; G M O'Donoghue
Journal:  Ear Hear       Date:  2000-06       Impact factor: 3.570

2.  Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).

Authors:  Miguel Arístegui; Antonio Denia
Journal:  Otol Neurotol       Date:  2005-03       Impact factor: 2.311

3.  Unilateral deafness after acoustic neuroma surgery: subjective hearing handicap and the effect of the bone-anchored hearing aid.

Authors:  Henrik Terkel Andersen; Stine Attrup Schrøder; Per Bonding
Journal:  Otol Neurotol       Date:  2006-09       Impact factor: 2.311

Review 4.  Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection.

Authors:  Syed Ahsan; Fred Telischi; Annelle Hodges; Thomas Balkany
Journal:  Laryngoscope       Date:  2003-03       Impact factor: 3.325

5.  Monaural versus binaural hearing: ease of listening, word recognition, and attentional effort.

Authors:  J F Feuerstein
Journal:  Ear Hear       Date:  1992-04       Impact factor: 3.570

6.  Spatial hearing disability after acoustic neuroma removal.

Authors:  Susan A Douglas; Phil Yeung; Anurag Daudia; Stuart Gatehouse; Gerard M O'Donoghue
Journal:  Laryngoscope       Date:  2007-09       Impact factor: 3.325

7.  Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2.

Authors:  Patrice Tran Ba Huy; Romain Kania; Bruno Frachet; Christine Poncet; Marie-Suzanne Legac
Journal:  Acta Otolaryngol       Date:  2009-09       Impact factor: 1.494

8.  Simultaneous translabyrinthine removal of acoustic neuroma and cochlear implantation.

Authors:  Diego Zanetti; Chiara Barbara Campovecchi; Sara Pasini; Nader Nassif
Journal:  Auris Nasus Larynx       Date:  2008-02-19       Impact factor: 1.863

9.  Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.

Authors:  Vincenzo Vincenti; Enrico Pasanisi; Maurizio Guida; Giuseppe Di Trapani; Mario Sanna
Journal:  Audiol Neurootol       Date:  2008-02-07       Impact factor: 1.854

10.  Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.

Authors:  Brian A Neff; R Mark Wiet; John M Lasak; Noel L Cohen; Harold C Pillsbury; Richard T Ramsden; D Bradley Welling
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

View more
  1 in total

1.  Management of transmodiolar and transmacular cochleovestibular schwannomas with and without cochlear implantation.

Authors:  S K Plontke; P Caye-Thomasen; C Strauss; S Kösling; G Götze; U Siebolts; D Vordermark; L Wagner; L Fröhlich; T Rahne
Journal:  HNO       Date:  2021-01       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.